Mario Apata1, Bernado Arriaza2, Elena Llop1, Mauricio Moraga1,3. 1. Programa de Genética Humana, ICBM, Facultad de Medicina, Universidad de Chile, Santiago, Chile. 2. Instituto de Alta Investigación, Universidad de Tarapacá, Arica, Chile. 3. Departamento de Antropología, Facultad de Ciencias Sociales, Universidad de Chile, Santiago, Chile.
Abstract
OBJECTIVES: Quebrada Camarones, in the Atacama Desert, has the highest arsenic levels in the Americas (>1,000 µg/L). However, the Camarones people have subsisted in this adverse environment during the last 7,000 years and have not presented any epidemiological emergencies. Therefore, to solve this conundrum we compared the frequencies of four protective genetic variants of the AS3MT gene associated with efficient arsenic metabolization, between the living populations of Camarones and two other populations historically exposed to lower levels of arsenic. MATERIALS AND METHODS: The Chilean selected population samples come from Quebrada Camarones (n = 50) and the Azapa Valley (n = 47) in the north and San Juan de la Costa (n = 45) in southern Chile. The genotyping was conducted using PCR-RFLP. We compared the genotypic and allelic frequencies, and estimated the haplotype frequencies in the AS3MT gene. RESULTS: We found higher frequencies of the protective variants in those people from Camarones than in the other two populations. The haplotype estimation showed that the combination of protective variants of CTTA is very frequent in Camarones (68%) and Azapa (48%), but extremely low in San Juan de la Costa (8%). Also, the C variant associated with toxicity risks in the SNP Met287Thr had a lower frequency in Camarones (1%) and is higher in the other populations. DISCUSSION: The higher frequency of protective variants in both northern Chilean populations indicates a long exposure to naturally arsenic-contaminated water sources. Our data suggest that a high arsenic metabolization capacity has been selected as an adaptive mechanism in these populations in order to survive in an arsenic-laden environment.
OBJECTIVES:Quebrada Camarones, in the Atacama Desert, has the highest arsenic levels in the Americas (>1,000 µg/L). However, the Camaronespeople have subsisted in this adverse environment during the last 7,000 years and have not presented any epidemiological emergencies. Therefore, to solve this conundrum we compared the frequencies of four protective genetic variants of the AS3MT gene associated with efficient arsenic metabolization, between the living populations of Camarones and two other populations historically exposed to lower levels of arsenic. MATERIALS AND METHODS: The Chilean selected population samples come from Quebrada Camarones (n = 50) and the Azapa Valley (n = 47) in the north and San Juan de la Costa (n = 45) in southern Chile. The genotyping was conducted using PCR-RFLP. We compared the genotypic and allelic frequencies, and estimated the haplotype frequencies in the AS3MT gene. RESULTS: We found higher frequencies of the protective variants in those people from Camarones than in the other two populations. The haplotype estimation showed that the combination of protective variants of CTTA is very frequent in Camarones (68%) and Azapa (48%), but extremely low in San Juan de la Costa (8%). Also, the C variant associated with toxicity risks in the SNP Met287Thr had a lower frequency in Camarones (1%) and is higher in the other populations. DISCUSSION: The higher frequency of protective variants in both northern Chilean populations indicates a long exposure to naturally arsenic-contaminated water sources. Our data suggest that a high arsenic metabolization capacity has been selected as an adaptive mechanism in these populations in order to survive in an arsenic-laden environment.
Authors: Rachel Simpson; David M L Cooper; Treena Swanston; Ian Coulthard; Tamara L Varney Journal: Archaeol Anthropol Sci Date: 2021-01-15 Impact factor: 1.989
Authors: Rocio Caro-Consuegra; Maria A Nieves-Colón; Erin Rawls; Verónica Rubin-de-Celis; Beatriz Lizárraga; Tatiana Vidaurre; Karla Sandoval; Laura Fejerman; Anne C Stone; Andrés Moreno-Estrada; Elena Bosch Journal: Mol Biol Evol Date: 2022-08-03 Impact factor: 8.800
Authors: Beverly H Koller; John N Snouwaert; Christelle Douillet; Leigh A Jania; Hisham El-Masri; David J Thomas; Miroslav Stýblo Journal: Environ Health Perspect Date: 2020-08-11 Impact factor: 9.031
Authors: Adebowale A Adeyemo; Daniel Shriner; Amy R Bentley; Rasheed A Gbadegesin; Charles N Rotimi Journal: Nat Rev Nephrol Date: 2021-09-28 Impact factor: 28.314